Key considerations and common myths

  • Focus on products and supply: The endgame targets the industry and its products, not those who use them. Stigmatizing people who use tobacco or nicotine and suffer from often life-long dependence must be avoided.
  • Integrate effective cessation support into tobacco endgame strategies and measures, particularly to impact health inequalities.
  • Prioritize measures with a substantial expected impact, based on the evidence and feasibility
  • Resist industry interference: Strictly adhere to Article 5.3 of the WHO FCTC. Scrutinize industry-driven harm reduction initiatives. These are self-serving tactics aimed at maintaining addiction and sales, obstructing policy, and attracting new users. Exercise caution around this concept, especially in areas with weaker regulations.

Further, promoting the commitment of political leaders and the intersectoral and civil society participation is often essential in getting forward-looking measures to the political agenda. Vulnerable population groups (e.g., adolescents, pregnant women, persons with low socio economic position or mental health problems) should be taken into consideration in the development, implementation, and evaluation of tobacco endgame goals. Especially in indigenous populations, it may be beneficial to clearly focus on commercial tobacco.

Common myths